Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbocysteine for pre-COPD in China
ChiCTR2400089858Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) and chronic bronchitis (CB) comparing Carbocysteine group with Placebo group (2 arms). Primary endpoint: Incidence of acute respiratory events (acute exacerbations). Planned start Sep 2024; status: not yet recruiting.
02
Drugs
carbocisteine
03
Conditions
chronic obstructive pulmonary disease (COPD)chronic bronchitis (CB)
Beyond the preview
Go deeper on ChiCTR2400089858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089858.